
Osteopore Ltd. Announces Quotation of New Securities on ASX

I'm PortAI, I can summarize articles.
Osteopore Ltd. announced the quotation of 16,949,152 new fully paid ordinary securities on the ASX, effective December 11, 2025. This strategic move aims to enhance its capital structure and expand market presence. Osteopore Ltd. specializes in bioresorbable implants for tissue regeneration in the medical technology industry. The current analyst rating for AU:OSX is Hold with a A$0.01 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

